The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
the pcsk9 Tio which is associated with a a lowered pcsk9 lowered pcsk9 means lower LDL and lower activity of pcsk9 was associated with a risk of type two diabetes in increased body mass index waste circumference waste of hip ratio diastolic blood pressure type 1 diabetes and insulin resuse
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the pcsk9 Tio which is associated with a a lowered pcsk9 lowered pcsk9 means lower LDL and lower activity of pcsk9 was associated with a risk of type two diabetes in increased body mass index waste circumference waste of hip ratio diastolic blood pressure type 1 diabetes and insulin resuse and this is saying that people who have low pcsk9 genetically don't do well they have more LDL receptors on the surface they pull more LDL into their organs and they're getting into a lot of problems
so for every 38.6 7 milligrams per deciliter of ldlc that was reduced for people who had these genetic variants with for pcsk9 there was a subsequent 19% increase in incidents of diabetes
Moreover these specific pcsk9 variants were associated with adverse metabolic consequences including increased fasting glucose increased body weight and an increased waste to hip ratio